Compounds > nitazoxanide
Page last updated: 2024-08-23

nitazoxanide and Antibiotic-Associated Colitis

nitazoxanide has been researched along with Antibiotic-Associated Colitis in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (70.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Galang, MA; Gerding, DN; Hecht, DW; Johnson, S; Osmolski, JR; Sambol, SP1
Bressler, AM; Johnson, DP; Logan, N; Musher, DM; Rossignol, JF1
Johnson, AP1
Bookstaver, PB; Miller, AD; Musgrave, CR; Sutton, SS1
Guerrant, RL; Hoffman, PS; Kolling, GL; Li, Y; Moore, JH; Riggins, MS; van Opstal, EJ; Warren, CA1
Dupont, HL; Gupta, A; Hamill, RJ; Lentnek, A; Logan, N; Musher, DM; Rossignol, JF1
Koletar, SL; Mangino, JE; Stevenson, KB; Young, JD1
Garud, S; Hamill, RJ; Logan, N; Mehendiratta, V; Melgarejo, NA; Musher, DM1
McVay, CS; Rolfe, RD1
Arya, SC1

Reviews

2 review(s) available for nitazoxanide and Antibiotic-Associated Colitis

ArticleYear
New antibiotics for selective treatment of gastrointestinal infection caused by Clostridium difficile.
    Expert opinion on therapeutic patents, 2010, Volume: 20, Issue:10

    Topics: Aminoglycosides; Anti-Bacterial Agents; Benzopyrans; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fidaxomicin; Glycopeptides; Humans; Lipoglycopeptides; Nitro Compounds; Thiazoles; Thiophenes

2010
Use of alternative or adjuvant pharmacologic treatment strategies in the prevention and treatment of Clostridium difficile infection.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2011, Volume: 15, Issue:7

    Topics: Aminoglycosides; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Immunotherapy; Nitro Compounds; Polymers; Probiotics; Thiazoles

2011

Trials

3 trial(s) available for nitazoxanide and Antibiotic-Associated Colitis

ArticleYear
Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Feb-15, Volume: 48, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Double-Blind Method; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Nitro Compounds; Prospective Studies; Thiazoles; Treatment Outcome; United States; Vancomycin

2009
Nitazoxanide for the treatment of Clostridium difficile colitis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Aug-15, Volume: 43, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Nitro Compounds; Thiazoles

2006
Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 59, Issue:4

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Nitro Compounds; Recurrence; Thiazoles; Treatment Failure

2007

Other Studies

5 other study(ies) available for nitazoxanide and Antibiotic-Associated Colitis

ArticleYear
In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8

    Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Humans; Microbial Sensitivity Tests; United States

2007
Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteroides; Cecum; Clostridioides difficile; Clostridium Infections; DNA, Bacterial; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Intestines; Male; Metronidazole; Mice; Mice, Inbred C57BL; Nitro Compounds; Recurrence; Thiazoles; Treatment Outcome; Vancomycin

2013
Nitazoxanide versus metronidazole for Clostridium difficile-associated colitis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Jan-01, Volume: 44, Issue:1

    Topics: Aged; Animals; Anti-Bacterial Agents; Clostridioides difficile; Cricetinae; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Nitro Compounds; Thiazoles; Treatment Outcome

2007
In vitro and in vivo activities of nitazoxanide against Clostridium difficile.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Metronidazole; Microbial Sensitivity Tests; Nitro Compounds; Thiazoles; Vancomycin

2000
Nitazoxanide as a broad-spectrum antiparasitic agent.
    The Journal of infectious diseases, 2002, Jun-01, Volume: 185, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Cricetinae; Enterocolitis, Pseudomembranous; Humans; Middle Aged; Nitro Compounds; Parasites; Parasitic Diseases; Thiazoles

2002